BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33128030)

  • 21. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
    Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
    Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
    Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
    BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.
    Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F
    Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor-1alpha suppressed hepatocellular carcinoma cell apoptosis through influencing on Omi/HtrA2 expression and its releasing from the mitochondrion.
    Xu Z; Chen X; Peng C; Liu E; Li Y; Li C; Niu J
    Oncol Res; 2012; 20(5-6):213-20. PubMed ID: 23581228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.
    Ma W; Shi X; Lu S; Wu L; Wang Y
    Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
    Liu LP; Ho RL; Chen GG; Lai PB
    Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D; Zhang X; Lu Y; Wang X; Zhu L
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.
    Daskalow K; Rohwer N; Raskopf E; Dupuy E; Kühl A; Loddenkemper C; Wiedenmann B; Schmitz V; Cramer T
    J Mol Med (Berl); 2010 Aug; 88(8):817-27. PubMed ID: 20383692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
    Liu KG; Xie HH; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression.
    Fang X; Zhang D; Zhao W; Gao L; Wang L
    Med Sci Monit; 2020 Aug; 26():e924670. PubMed ID: 32772041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA.
    Shi L; Zhang G; Zheng Z; Lu B; Ji L
    Chem Biol Interact; 2017 Aug; 273():228-236. PubMed ID: 28651835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].
    Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C
    Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tirapazamine sensitizes hepatocellular carcinoma cells to topoisomerase I inhibitors via cooperative modulation of hypoxia-inducible factor-1α.
    Cai TY; Liu XW; Zhu H; Cao J; Zhang J; Ding L; Lou JS; He QJ; Yang B
    Mol Cancer Ther; 2014 Mar; 13(3):630-42. PubMed ID: 24362462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.
    Kim Y; Jang M; Lim S; Won H; Yoon KS; Park JH; Kim HJ; Kim BH; Park WS; Ha J; Kim SS
    Hepatology; 2011 Nov; 54(5):1661-78. PubMed ID: 21748762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
    Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
    Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.